CS logo
small CS logo
Oncology Associates at Mercy Medical Center

Cedar Rapids, Iowa, United States
Oncologist in Cedar Rapids, Iowa
701 10th St SE, Cedar Rapids, IA 52401

About Oncology Associates at Mercy Medical Center


"Oncology Associates at Mercy Medical Center provides high-quality hematology and oncology care for cancer patients close to home."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Alliance for Clinical Trials in Oncology
96
National Cancer Institute (NCI)
80
SWOG Cancer Research Network
22
Eastern Cooperative Oncology Group
15
ECOG-ACRIN Cancer Research Group
13
NSABP Foundation Inc
6
Wake Forest University Health Sciences
5
Academic and Community Cancer Research United
2
Astellas Pharma Inc
2
GOG Foundation
2
Hoffmann-La Roche
2
Total Rows: 30

Clinical Trials at Oncology Associates at Mercy Medical Center


During the past decade, Oncology Associates at Mercy Medical Center conducted 61 clinical trials. In the 10-year time frame, 61 clinical trials started and 120 clinical trials were completed, i.e. on average, 196.7% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 28 clinical trials were completed. i.e. 164.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission
1993-04-01
Completed
1,929
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
1997-03-01
2012-01-01
Completed
212
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
1998-10-01
2004-10-01
Completed
1,691
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1998-10-01
2016-12-01
Completed
682
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
1999-12-01
2022-05-20
Completed
636
S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
1999-10-15
2018-05-01
Completed
983

Rows per page:

1–100 of 267

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Oncology Associates at Mercy Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 96 trials, followed by "National Cancer Institute (NCI)" with 80 trials sponsored, "SWOG Cancer Research Network" with 22 trials sponsored, "Eastern Cooperative Oncology Group" with 15 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 30 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Associates at Mercy Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 170 trials as a collaborator, "NCIC Clinical Trials Group" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 14 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator and "SWOG Cancer Research Network" with 11 trials as a collaborator. Other collaborators include 64 different institutions and companies that were collaborators in the rest 44 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAlliance for ClinicalTrials in Oncology: 96Alliance for ClinicalTrials in Oncology: 96National CancerInstitute (NCI): 80National CancerInstitute (NCI): 80SWOG Cancer ResearchNetwork: 22SWOG Cancer ResearchNetwork: 22Eastern CooperativeOncology Group: 15Eastern CooperativeOncology Group: 15ECOG-ACRIN CancerResearch Group: 13ECOG-ACRIN CancerResearch Group: 13NSABP Foundation Inc: 6NSABP Foundation Inc: 6Wake Forest UniversityHealth Sciences: 5Wake Forest UniversityHealth Sciences: 5Academic andCommunity CancerResearch United: 2Academic andCommunity CancerResearch United: 2Astellas Pharma Inc: 2Astellas Pharma Inc: 2GOG Foundation: 2GOG Foundation: 2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 170National CancerInstitute (NCI): 170NCIC Clinical Trials Group: 15NCIC Clinical Trials Group: 15Cancer and LeukemiaGroup B: 14Cancer and LeukemiaGroup B: 14NRG Oncology: 13NRG Oncology: 13SWOG Cancer ResearchNetwork: 11SWOG Cancer ResearchNetwork: 11North Central CancerTreatment Group: 10North Central CancerTreatment Group: 10Eastern CooperativeOncology Group: 7Eastern CooperativeOncology Group: 7Canadian Cancer Trials Group: 4Canadian Cancer Trials Group: 4Bristol-Myers Squibb: 3Bristol-Myers Squibb: 3Mayo Clinic: 3Mayo Clinic: 3

Clinical Trials Conditions at Oncology Associates at Mercy Medical Center


According to Clinical.Site data, the most researched conditions in "Oncology Associates at Mercy Medical Center" are "Breast Cancer" (36 trials), "Lung Cancer" (19 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials), "Colorectal Cancer" (13 trials) and "Pain" (8 trials). Many other conditions were trialed in "Oncology Associates at Mercy Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at Oncology Associates at Mercy Medical Center


Most popular intervention types in "Oncology Associates at Mercy Medical Center" are "Drug" (218 trials), "Other" (132 trials), "Biological" (95 trials), "Procedure" (44 trials) and "Radiation" (33 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (47 trials), "Quality-of-Life Assessment" (42 trials), "placebo" (34 trials), "Paclitaxel" (22 trials) and "Questionnaire Administration" (22 trials). Other intervention names were less common.

Clinical Trials Genders at Oncology Associates at Mercy Medical Center


The vast majority of trials in "Oncology Associates at Mercy Medical Center" are 216 trials for "All" genders, 43 trials for "Female" genders and 7 trials for "Male" genders.

Clinical Trials Status at Oncology Associates at Mercy Medical Center


Currently, there are NaN active trials in "Oncology Associates at Mercy Medical Center". undefined are not yet recruiting, 26 are recruiting, 72 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 143 completed trials in Oncology Associates at Mercy Medical Center, 4 suspended trials, and 19 terminated clinical trials to date.
Out of the total trials that were conducted in Oncology Associates at Mercy Medical Center, 10 "Phase 1" clinical trials were conducted, 102 "Phase 2" clinical trials and 142 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 142Phase 3: 142Phase 2: 102Phase 2: 102Phase 1: 10Phase 1: 10Not Applicable: 8Not Applicable: 8Early Phase 1: 1Early Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 143Completed: 143Active, not recruiting: 72Active, not recruiting: 72Recruiting: 26Recruiting: 26Terminated: 19Terminated: 19Suspended: 4Suspended: 4Unknown status: 3Unknown status: 3